Screener
Omada Health OMDA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Omada Health in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Omada Health’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054840
FAQ
- What is Omada Health's cash & equivalents?
- Omada Health (OMDA) reported cash & equivalents of $221.71M in Q2 2026.
- How has Omada Health's cash & equivalents changed year-over-year?
- Omada Health's cash & equivalents decreased by 0.6% year-over-year, from $223.15M to $221.71M.
- What is the long-term trend for Omada Health's cash & equivalents?
- Over 2 years (2023 to 2025), Omada Health's cash & equivalents has grown at a 38.6% compound annual growth rate (CAGR), from $115.64M to $222.04M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Omada Health's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude